|
Volumn 251, Issue 5, 2002, Pages 421-428
|
Effect of medroxyprogesterone on pulmonary arterial pressure, exhaled nitric oxide, ECG and arterial blood gases
|
Author keywords
Chronic obstructive pulmonary disease; Electrocardiography; Hormone replacement therapy; Medroxyprogesterone acetate; Menopause; Pulmonary pressure
|
Indexed keywords
MEDROXYPROGESTERONE ACETATE;
NITRIC OXIDE;
ADULT;
AGED;
ARTERIAL CARBON DIOXIDE TENSION;
ARTICLE;
BLOOD PRESSURE MONITORING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIASTOLIC BLOOD PRESSURE;
DOPPLER ECHOCARDIOGRAPHY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG SCREENING;
ELECTROCARDIOGRAPHY;
EXHALATION;
FEMALE;
FINLAND;
HEART RATE;
HUMAN;
LUNG ARTERY PRESSURE;
POSTMENOPAUSE;
PR INTERVAL;
PRIORITY JOURNAL;
QRS COMPLEX;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY DISTRESS;
SYSTOLIC BLOOD PRESSURE;
UNIVERSITY HOSPITAL;
AGED;
BLOOD GAS ANALYSIS;
BLOOD PRESSURE;
CHILD;
DOUBLE-BLIND METHOD;
ELECTROCARDIOGRAPHY;
HUMANS;
INFANT;
MEDROXYPROGESTERONE 17-ACETATE;
NITRIC OXIDE;
PULMONARY ARTERY;
|
EID: 0036095135
PISSN: 09546820
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2796.2002.00980.x Document Type: Article |
Times cited : (4)
|
References (31)
|